VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ICU
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ICUSeaStar Medical Holding Corporation
$3.55$139M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksICUQuarterly Financials

SeaStar Medical Holding Corporation (ICU) Quarterly Financials

120+ quarters historyFree accessUpdated daily

SeaStar Medical Holding Corporation (ICU) quarterly income statement — complete revenue, gross profit & net income history

ICU Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue495K420K183K338K293K67K68K00000
Revenue Growth %68.94%526.87%169.12%---------
Cost of Goods Sold46K12K14K27K00000000
COGS % of Revenue9.29%2.86%7.65%7.99%--------
Gross Profit449K408K169K311K293K67K68K00000
Gross Margin %90.71%97.14%92.35%92.01%100%100%100%-----
Gross Profit Growth %53.24%508.96%148.53%---------
Operating Expenses4.05M3.42M3.75M2.07M4.12M4.83M4.52M4.67M3.95M2.94M2.94M3.75M
OpEx % of Revenue818.59%815.24%2048.09%611.54%1404.44%7214.93%6652.94%-----
Selling, General & Admin1.71M1.22M1.9M1.03M1.68M2.1M2.19M2.33M2.25M1.96M1.85M1.77M
SG&A % of Revenue345.05%291.43%1037.16%304.73%574.74%3128.36%3217.65%-----
Research & Development2.34M2.2M1.85M1.04M2.43M2.74M2.34M2.33M1.7M1.18M1.09M1.98M
R&D % of Revenue473.54%523.81%1010.93%306.8%829.69%4086.57%3435.29%-----
Other Operating Expenses000000000-193.8K00
Operating Income-3.6M-3.02M-3.58M-1.76M-3.82M-4.77M-4.46M-4.67M-3.95M-2.94M-2.94M-3.75M
Operating Margin %-727.88%-718.1%-1955.74%-519.53%-1304.44%-7114.93%-6552.94%-----
Operating Income Growth %5.73%36.73%19.68%62.39%3.24%-61.98%-51.46%-24.51%13.77%61.86%-66.31%-185.82%
EBITDA-3.6M-2.89M-3.57M-1.99M-3.76M-5.02M-4.21M-3.15M-12.55M-9.68M-7.01M-2.22M
EBITDA Margin %-727.88%-688.33%-1951.91%-589.64%-1282.59%-7492.54%-6185.29%-----
EBITDA Growth %4.12%42.41%15.07%36.75%70.07%48.15%39.98%-42.13%-88.41%--296.38%-211.81%
D&A (Non-Cash Add-back)007K00-253K000000
EBIT-3.6M-2.89M-3.47M-1.99M-3.76M-4.42M-4.21M-3.15M-12.55M-9.68M-7.01M-2.22M
Net Interest Income85K112K107K-262K37K272K-214K-57K-143K-199K-224K-225K
Interest Income91K125K107K45K48K19K58K25K0000
Interest Expense6K13K0307K11K-253K272K82K143K199K224K225K
Other Income/Expense85K112K107K-246K53K348K-22K1.44M-8.75M-6.94M-4.29M1.31M
Pretax Income-3.52M-2.9M-3.47M-2M-3.77M-4.42M-4.48M-3.23M-12.7M-9.88M-7.23M-2.44M
Pretax Margin %-710.71%-691.43%-1897.27%-592.31%-1286.35%-6595.52%-6585.29%-----
Income Tax3K0003K003K0-5K05K
Effective Tax Rate %-0.09%0%0%0%-0.08%0%0%-0.09%0%0.05%0%-0.2%
Net Income-3.52M-2.9M-3.47M-2M-3.77M-4.42M-4.48M-3.24M-12.7M-9.88M-7.23M-2.45M
Net Margin %-711.31%-691.43%-1897.27%-592.31%-1287.37%-6595.52%-6585.29%-----
Net Income Growth %6.65%34.28%22.47%38.13%70.29%55.25%38.08%-32.24%-78.93%-17.67%-282.24%-171.29%
Net Income (Continuing)-3.52M-2.9M-3.47M-2M-3.77M-4.42M-4.48M-3.24M-12.7M-9.88M-7.23M-2.45M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)-0.90-0.80-1.30-1.10-4.40-9.00-11.00-10.26-47.30-51.85-90.20-41.00
EPS Growth %79.55%91.11%88.18%89.28%90.7%82.64%87.8%74.98%64.96%87.99%-142.47%-136.99%
EPS (Basic)-0.90-0.80-1.30-1.10-4.40-9.00-11.00-10.26-47.30-51.85-90.20-41.00
Diluted Shares Outstanding39.18M20.73M2.64M1.75M861.8K492K408.7K315.48K268.42K190.46K80.19K59.73K
Basic Shares Outstanding39.18M20.73M2.64M1.75M861.8K492K408.7K315.48K268.42K190.46K80.1K59.7K
Dividend Payout Ratio------------